Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

A new study led by scientists at the Perception Dynamics Institute and the University of California San Diego demonstrates that a specific visual training program significantly outperforms standard ...